Kenneth R. Hess

62.8k total citations · 14 hit papers
509 papers, 41.8k citations indexed

About

Kenneth R. Hess is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Kenneth R. Hess has authored 509 papers receiving a total of 41.8k indexed citations (citations by other indexed papers that have themselves been cited), including 191 papers in Oncology, 175 papers in Pulmonary and Respiratory Medicine and 127 papers in Cancer Research. Recurrent topics in Kenneth R. Hess's work include Glioma Diagnosis and Treatment (87 papers), Cancer Genomics and Diagnostics (58 papers) and Brain Metastases and Treatment (45 papers). Kenneth R. Hess is often cited by papers focused on Glioma Diagnosis and Treatment (87 papers), Cancer Genomics and Diagnostics (58 papers) and Brain Metastases and Treatment (45 papers). Kenneth R. Hess collaborates with scholars based in United States, China and France. Kenneth R. Hess's co-authors include Joseph S. Coselli, Hazim J. Safi, E. Stanley Crawford, Lars G. Svensson, Raymond Sawaya, Gabriel N. Hortobágyi, Lajos Pusztai, James L. Abbruzzese, W. Fraser Symmans and Frederick F. Lang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and JAMA.

In The Last Decade

Kenneth R. Hess

499 papers receiving 40.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

2001 2.3k citations Frederick F. Lang, Kenneth R. Hess et al. profile →
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

2008 2.2k citations Cornelia Liedtke, Chafika Mazouni et al. Journal of Clinical Oncology profile →
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial

2009 1.8k citations Kenneth R. Hess, Frederick F. Lang et al. profile →
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

2017 1.4k citations Kenneth R. Hess et al. profile →
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

2005 1.4k citations Roman Rouzier, Charles M. Perou et al. Clinical Cancer Research profile →
Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases

2004 1.3k citations Lee M. Ellis, Kenneth R. Hess et al. profile →
Experience with 1509 patients undergoing thoracoabdominal aortic operations

1993 931 citations Kenneth R. Hess et al. profile →
Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials

1999 722 citations Kenneth R. Hess et al. Journal of Clinical Oncology profile →
Thoracoabdominal aortic aneurysms: Preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients

1986 639 citations Kenneth R. Hess et al. profile →
Metastatic patterns in adenocarcinoma

2006 636 citations Kenneth R. Hess et al. Cancer profile →
Thoracoabdominal aortic aneurysms: Preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients

1986 621 citations Kenneth R. Hess et al. profile →
Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer

2006 553 citations Kenneth R. Hess, K. Anderson et al. Journal of Clinical Oncology profile →
Deep hypothermia with circulatory arrest. Determinants of stroke and early mortality in 656 patients.

1993 466 citations Kenneth R. Hess et al. profile →
The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?

2015 456 citations Kenneth R. Hess et al. profile →

Peers

Kenneth R. Hess

ONCOL

PRM

GENET

Luigi Mariani Italy

James E. Herndon United States

Seth M. Steinberg United States

Minesh P. Mehta United States

Elizabeth A. Eisenhauer Canada

Razelle Kurzrock United States

Jaap Verweij Netherlands

Denis Lacombe Belgium

Jürgen Debus Germany

Karla V. Ballman United States

Luigi Mariani Italy

Kenneth R. Hess

10.6k ×0.7

ONCOL

8.8k ×0.6

PRM

6.6k ×0.7

5.0k ×0.6

GENET

8.2k ×1.0

Citations per year, relative to Kenneth R. Hess Kenneth R. Hess (= 1×) peers Luigi Mariani

Countries citing papers authored by Kenneth R. Hess

Since Specialization

Citations

This map shows the geographic impact of Kenneth R. Hess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth R. Hess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth R. Hess more than expected).

Fields of papers citing papers by Kenneth R. Hess

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth R. Hess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth R. Hess. The network helps show where Kenneth R. Hess may publish in the future.

Co-authorship network of co-authors of Kenneth R. Hess

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth R. Hess. A scholar is included among the top collaborators of Kenneth R. Hess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth R. Hess. Kenneth R. Hess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liedtke, Cornelia, Chafika Mazouni, Kenneth R. Hess, et al.. (2023). Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer. Journal of Clinical Oncology. 41(10). 1809–1815. 62 indexed citations

Subbiah, Vivek, Pete Anderson, Kalevi Kairemo, et al.. (2019). Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation Trial. Clinical Cancer Research. 25(13). 3802–3810. 32 indexed citations

Hess, Kenneth R., Filip Jankú, Nora Sánchez, et al.. (2019). Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer. Clinical Cancer Research. 26(8). 1924–1931. 40 indexed citations

Chen, Xian, Angela Alexander, Yufeng Jiang, et al.. (2018). Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition. Clinical Cancer Research. 24(24). 6594–6610. 78 indexed citations

Bugano, Diogo Diniz Gomes, Kenneth R. Hess, Denis L. Jardim, et al.. (2017). Use of Expansion Cohorts in Phase I Trials and Probability of Success in Phase II for 381 Anticancer Drugs. Clinical Cancer Research. 23(15). 4020–4026. 17 indexed citations

Kehl, Kenneth L., Siqing Fu, Goldy C. George, et al.. (2017). Insurance Clearance for Early-Phase Oncology Clinical Trials Following the Affordable Care Act. Clinical Cancer Research. 23(15). 4155–4162. 4 indexed citations

Ghia, Amol J., Kenneth R. Hess, Jinzhong Yang, et al.. (2017). Phase 1 Study of Spinal Cord Constraint Relaxation with Single Session Spine Stereotactic Radiosurgery in the Primary Management of Patients with Inoperable, Previously Unirradiated Metastatic Epidural Spinal Cord Compression. International Journal of Radiation Oncology*Biology*Physics. 99(2). S157–S157. 4 indexed citations

Hossain, Mohammad B., Jingyi Li, Xuemei Luo, et al.. (2017). TIE2 Associates with Caveolae and Regulates Caveolin-1 To Promote Their Nuclear Translocation. Molecular and Cellular Biology. 37(21). 13 indexed citations

Tang, Chad, James W. Welsh, Patricia M. de Groot, et al.. (2016). Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells. Clinical Cancer Research. 23(6). 1388–1396. 251 indexed citations

10.

Tang, Chad, Kenneth R. Hess, Suzanne E. Davis, et al.. (2016). Modifying the Clinical Research Infrastructure at a Dedicated Clinical Trials Unit: Assessment of Trial Development, Activation, and Participant Accrual. Clinical Cancer Research. 23(6). 1407–1413. 9 indexed citations

11.

Yuan, Ying, Kenneth R. Hess, Susan G. Hilsenbeck, & Mark R. Gilbert. (2016). Bayesian Optimal Interval Design: A Simple and Well-Performing Design for Phase I Oncology Trials. Clinical Cancer Research. 22(17). 4291–4301. 131 indexed citations

12.

Jardim, Denis L., Chad Tang, Débora De Melo Gagliato, et al.. (2014). Analysis of 1,115 Patients Tested for MET Amplification and Therapy Response in the MD Anderson Phase I Clinic. Clinical Cancer Research. 20(24). 6336–6345. 65 indexed citations

13.

Tang, Chad, Kenneth R. Hess, Denis L. Jardim, et al.. (2014). Synergy Between VEGF/VEGFR Inhibitors and Chemotherapy Agents in the Phase I Clinic. Clinical Cancer Research. 20(23). 5956–5963. 11 indexed citations

14.

Jardim, Denis L., Kenneth R. Hess, Patricia LoRusso, Razelle Kurzrock, & David S. Hong. (2013). Predictive Value of Phase I Trials for Safety in Later Trials and Final Approved Dose: Analysis of 61 Approved Cancer Drugs. Clinical Cancer Research. 20(2). 281–288. 39 indexed citations

15.

Tabchy, Adel, Vicente Valero, Tatiana Vidaurre, et al.. (2010). Evaluation of a 30-Gene Paclitaxel, Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy Response Predictor in a Multicenter Randomized Trial in Breast Cancer. Clinical Cancer Research. 16(21). 5351–5361. 160 indexed citations

16.

Moulder, Stacy, Kai Yan, Fei Huang, et al.. (2010). Development of Candidate Genomic Markers to Select Breast Cancer Patients for Dasatinib Therapy. Molecular Cancer Therapeutics. 9(5). 1120–1127. 27 indexed citations

17.

Anderson, K., Kenneth R. Hess, Mini Kapoor, et al.. (2006). Reproducibility of Gene Expression Signature–Based Predictions in Replicate Experiments. Clinical Cancer Research. 12(6). 1721–1727. 22 indexed citations

18.

Rouzier, Roman, Charles M. Perou, W. Fraser Symmans, et al.. (2005). Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy. Clinical Cancer Research. 11(16). 5678–5685. 1414 indexed citations breakdown →

19.

Symmans, W. Fraser, Mark Ayers, Edwin Clark, et al.. (2003). Total RNA yield and microarray gene expression profiles from fine‐needle aspiration biopsy and core‐needle biopsy samples of breast carcinoma. Cancer. 97(12). 2960–2971. 140 indexed citations

20.

Lee, J. Jack, Kenneth R. Hess, & Joel A. Dubin. (2000). Extensions and Applications of Event Charts. The American Statistician. 54(1). 63–70. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact